• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟会增加幽门螺杆菌根除治疗失败的几率。

Smoking increases the treatment failure for Helicobacter pylori eradication.

作者信息

Suzuki Takeshi, Matsuo Keitaro, Ito Hidemi, Sawaki Akira, Hirose Kaoru, Wakai Kenji, Sato Shigeki, Nakamura Tsuneya, Yamao Kenji, Ueda Ryuzo, Tajima Kazuo

机构信息

Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.

出版信息

Am J Med. 2006 Mar;119(3):217-24. doi: 10.1016/j.amjmed.2005.10.003.

DOI:10.1016/j.amjmed.2005.10.003
PMID:16490464
Abstract

PURPOSE

Treatment failure for Helicobacter pylori (H. pylori) eradication is encountered in approximately 10-20% of patients, and many studies have pointed to a link with smoking. To investigate the effects of smoking on eradication outcome, we performed a meta-analysis.

METHODS

A PubMed search was performed to retrieve articles published up to August 2005. Pooled odds ratio (OR) and differences rate for H. pylori eradication failure in smokers compared with nonsmokers were used as summary statistics. Meta-regression was used for examining the source of heterogeneity.

RESULTS

Twenty-two published studies (5538 patients), which provided information on eradication failure according to smoking status, were included in the analysis. The summary OR for eradication failure among smokers relative to nonsmokers was 1.95 (95% confidence interval [CI]: 1.55-2.45; P <.01). It corresponds with the differences in eradication rates between smokers and nonsmokers (8.4% [95% CI: 3.3-13.5%, P <.01]). Meta-regression analysis demonstrated that a high proportion of nonulcer dyspepsia patients in studies revealed a higher failure rate among smokers, compared with a low proportion of nonulcer dyspepsia.

CONCLUSIONS

Our meta-analysis demonstrated that smoking increases the treatment failure rate for H. pylori eradication.

摘要

目的

幽门螺杆菌(H. pylori)根除治疗失败在约10%-20%的患者中出现,许多研究指出这与吸烟有关。为研究吸烟对根除结果的影响,我们进行了一项荟萃分析。

方法

在PubMed上进行检索,以获取截至2005年8月发表的文章。将吸烟者与非吸烟者相比幽门螺杆菌根除失败的合并比值比(OR)和差异率用作汇总统计量。采用Meta回归分析来检查异质性来源。

结果

分析纳入了22项已发表研究(5538例患者),这些研究提供了根据吸烟状况的根除失败信息。吸烟者相对于非吸烟者根除失败的汇总OR为1.95(95%置信区间[CI]:1.55-2.45;P<.01)。这与吸烟者和非吸烟者之间根除率的差异(8.4%[95%CI:3.3-13.5%,P<.01])相符。Meta回归分析表明,研究中高比例的非溃疡性消化不良患者显示吸烟者的失败率高于低比例非溃疡性消化不良患者。

结论

我们的荟萃分析表明,吸烟会增加幽门螺杆菌根除治疗的失败率。

相似文献

1
Smoking increases the treatment failure for Helicobacter pylori eradication.吸烟会增加幽门螺杆菌根除治疗失败的几率。
Am J Med. 2006 Mar;119(3):217-24. doi: 10.1016/j.amjmed.2005.10.003.
2
Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.荟萃分析:补充益生菌对幽门螺杆菌根除治疗期间根除率和不良事件的影响
Aliment Pharmacol Ther. 2007 Jan 15;25(2):155-68. doi: 10.1111/j.1365-2036.2006.03179.x.
3
Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication.荟萃分析:质子泵抑制剂预处理对幽门螺杆菌根除的影响
Aliment Pharmacol Ther. 2005 Feb 15;21(4):341-5. doi: 10.1111/j.1365-2036.2005.02329.x.
4
Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during Helicobacter pylori eradication therapy.荟萃分析:乳铁蛋白补充剂对幽门螺杆菌根除治疗期间根除率及不良事件的影响
Helicobacter. 2009 Apr;14(2):119-27. doi: 10.1111/j.1523-5378.2009.00666.x.
5
[Eradication of Helicobacter pylori infection in Hungary (1993-2002): a meta-analysis].[匈牙利幽门螺杆菌感染的根除情况(1993 - 2002年):一项荟萃分析]
Orv Hetil. 2003 Jun 1;144(22):1077-83.
6
Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.三联疗法根除幽门螺杆菌:土耳其10年趋势的流行病学分析
Clin Ther. 2006 Nov;28(11):1960-6. doi: 10.1016/j.clinthera.2006.11.011.
7
Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.荟萃分析:含乳酸杆菌的四联疗法与标准三联一线疗法根除幽门螺杆菌的对比
Helicobacter. 2009 Oct;14(5):97-107. doi: 10.1111/j.1523-5378.2009.00716.x.
8
Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.幽门螺杆菌感染二线治疗的根除率:非溃疡性消化不良与消化性溃疡疾病的比较。
Hepatogastroenterology. 2007 Jun;54(76):1293-6.
9
Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.甲硝唑作为二线药物治疗日本人群幽门螺杆菌感染的疗效:东京都地区的一项多中心研究。
Helicobacter. 2006 Jun;11(3):152-8. doi: 10.1111/j.1523-5378.2006.00394.x.
10
Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication.荟萃分析:牛乳铁蛋白在幽门螺杆菌根除中的疗效。
Aliment Pharmacol Ther. 2009 Apr 1;29(7):720-30. doi: 10.1111/j.1365-2036.2009.03934.x.

引用本文的文献

1
Hookah Smoking and Risk of Infection: Insights From a Case-Control Study in Iran.水烟吸食与感染风险:来自伊朗一项病例对照研究的见解
Health Sci Rep. 2025 Aug 6;8(8):e70993. doi: 10.1002/hsr2.70993. eCollection 2025 Aug.
2
LOW-NICKEL DIET AS A STRATEGY IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION.低镍饮食作为幽门螺杆菌感染治疗的一种策略。
Arq Gastroenterol. 2025 Jul 21;62:e24108. doi: 10.1590/S0004-2803.24612024-108. eCollection 2025.
3
Impact of supplementing Limosilactobacillus fermentum MN-LF23 on the eradication of Helicobacter pylori with 14-day standard quadruple therapy: a randomized, double-blind, placebo-controlled trial.
补充发酵乳杆菌MN-LF23对14天标准四联疗法根除幽门螺杆菌的影响:一项随机、双盲、安慰剂对照试验
Nutr J. 2025 Jul 7;24(1):106. doi: 10.1186/s12937-025-01124-6.
4
Efficacy and cost-effectiveness analysis of 10-day versus 14-day eradication of infection with vonoprazan amoxicillin: a prospective, multicenter, randomized controlled trial.沃克沙星联合阿莫西林治疗10天与14天根除感染的疗效和成本效益分析:一项前瞻性、多中心、随机对照试验。
Front Pharmacol. 2025 Mar 24;16:1543352. doi: 10.3389/fphar.2025.1543352. eCollection 2025.
5
Effectiveness of Susceptibility-Guided Therapy for Infection: A Retrospective Analysis by Propensity Score Matching.药敏指导治疗对感染的有效性:倾向评分匹配的回顾性分析
Infect Drug Resist. 2025 Feb 25;18:1149-1159. doi: 10.2147/IDR.S498052. eCollection 2025.
6
eradication for primary prevention of gastric cancer: progresses and challenges.胃癌一级预防中的根除治疗:进展与挑战
J Natl Cancer Cent. 2024 Jul 20;4(4):299-310. doi: 10.1016/j.jncc.2024.06.006. eCollection 2024 Dec.
7
Efficacy and safety of low-dose tetracycline, amoxicillin quadruple therapy in infection: A retrospective single center study.低剂量四环素、阿莫西林四联疗法治疗感染的疗效和安全性:一项回顾性单中心研究。
World J Gastroenterol. 2024 Oct 21;30(39):4295-4304. doi: 10.3748/wjg.v30.i39.4295.
8
Vonoprazan a novel potassium competitive acid blocker; another leap forward.沃克(富马酸伏诺拉生)——一种新型钾离子竞争性酸阻滞剂;又一次重大进展。
Prz Gastroenterol. 2024;19(2):135-142. doi: 10.5114/pg.2024.139426. Epub 2024 May 8.
9
Eradication Rate and Factors Influencing Infection Clearance Using Standard Triple Therapy at a Single Centre in Jazan Region, Saudi Arabia: A Retrospective Study.沙特阿拉伯吉赞地区某单一中心采用标准三联疗法的根除率及影响感染清除的因素:一项回顾性研究
Int J Gen Med. 2024 Jun 5;17:2627-2634. doi: 10.2147/IJGM.S456865. eCollection 2024.
10
Predictors of Successful First-Line Eradication with Fluoroquinolones in Pakistan: A Prospective Exploration of Demographic and Clinical Factors.巴基斯坦使用氟喹诺酮类药物进行一线根除治疗成功的预测因素:人口统计学和临床因素的前瞻性探索
Antibiotics (Basel). 2024 Feb 23;13(3):211. doi: 10.3390/antibiotics13030211.